Table 1 Patient rheumatologic and serum data at baseline and reassessment
Parameter | Case 1 | Case 2 | ||
|---|---|---|---|---|
Baseline | Reassessment | Baseline | Reassessment | |
Rheumatologic | ||||
SDAI | 12.3 | 4.5 | 16.0 | 4.0 |
DAS28-CRP | 2.3 | 2.9 | 2.9 | 2.1 |
TJC | 2 | 3 | 3 | 1 |
SJC | 0 | 0 | 4 | 1 |
gVAS (mm) | 51 | 7 | 45 | 10 |
Serum | ||||
RF (IU/mL) | 5.0 | 7.0 | 237.0 | 174.0 |
anti-CCP IgG (U/mL) | 37.8 | 25.7 | 247.0 | 301.0 |
CRP (mg/dL) | 0.1 | 0.1 | 0.01 | 0.01 |
MMP-3 (ng/mL) | 67.7 | 70.0 | 49.9 | 44.3 |
IL-6 (pg/mL) | 2.2 | 1.5 | 1.9 | 0.9 |
TNF-α (pg/mL) | 1.2 | 0.0 | 1.0 | 0.9 |